Citigroup analyst issues NEUTRAL recommendation for CINF on April 15, 2024 08:53PM ET. The previous analyst recommendation was Neutral.CINF was trading at $116.8 at issue of the analyst recommendation.The overall...
Barclays analyst issues EQUAL-WEIGHT recommendation for CL on April 12, 2024 05:10AM ET. The previous analyst recommendation was Equal-Weight.CL was trading at $86 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for PG on April 12, 2024 05:12AM ET. The previous analyst recommendation was Overweight.PG was trading at $155.84 at issue of the analyst recommendation.The overall...
Barclays analyst issues EQUAL-WEIGHT recommendation for KMB on April 12, 2024 05:11AM ET. The previous analyst recommendation was Equal-Weight.KMB was trading at $126.08 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for PEP on April 12, 2024 05:12AM ET. The previous analyst recommendation was Overweight.PEP was trading at $168.36 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for KO on April 12, 2024 05:13AM ET. The previous analyst recommendation was Overweight.KO was trading at $59.05 at issue of the analyst recommendation.The overall...
UBS analyst issues SECTOR PERFORM recommendation for PPG on April 9, 2024 08:00AM ET. The previous analyst recommendation was Sector Perform.PPG was trading at $139.91 at issue of the analyst...
RBC Capital analyst issues UNDERPERFORM recommendation for PPG on April 9, 2024 08:00AM ET. The previous analyst recommendation was Underperform.PPG was trading at $139.91 at issue of the analyst recommendation.The...
Piper Sandler analyst issues OVERWEIGHT recommendation for KVUE on April 9, 2024 05:43AM ET. The previous analyst recommendation was Overweight.KVUE was trading at $20.06 at issue of the analyst recommendation.The...
Wolfe Research analyst issues OUTPERFORM recommendation for EMR on April 8, 2024 02:00PM ET. The previous analyst recommendation was Outperform.EMR was trading at $114.89 at issue of the analyst recommendation.The...
